Oncogenic reg IV is a novel prognostic marker for glioma patient survival

<p>Abstract</p> <p>Aim</p> <p>The aberrant expression of regenerating islet-derived family member, 4 (Reg IV) has been found in various human cancers. However, the roles of Reg IV gene and its encoding product in human glioma have not been clearly understood. Therefore,...

Full description

Saved in:
Bibliographic Details
Main Authors: Wang Qi (Author), Deng Jianping (Author), Yuan Jun (Author), Wang Liang (Author), Zhao Zhenwei (Author), He Shiming (Author), Zhang Yongsheng (Author), Tu Yanyang (Author)
Format: Book
Published: BMC, 2012-06-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_adbb04d8b2b0402a9245f1b84c7890c4
042 |a dc 
100 1 0 |a Wang Qi  |e author 
700 1 0 |a Deng Jianping  |e author 
700 1 0 |a Yuan Jun  |e author 
700 1 0 |a Wang Liang  |e author 
700 1 0 |a Zhao Zhenwei  |e author 
700 1 0 |a He Shiming  |e author 
700 1 0 |a Zhang Yongsheng  |e author 
700 1 0 |a Tu Yanyang  |e author 
245 0 0 |a Oncogenic reg IV is a novel prognostic marker for glioma patient survival 
260 |b BMC,   |c 2012-06-01T00:00:00Z. 
500 |a 10.1186/1746-1596-7-69 
500 |a 1746-1596 
520 |a <p>Abstract</p> <p>Aim</p> <p>The aberrant expression of regenerating islet-derived family member, 4 (Reg IV) has been found in various human cancers. However, the roles of Reg IV gene and its encoding product in human glioma have not been clearly understood. Therefore, the aim of this study was to investigate the clinicopathological significance of Reg IV expression in glioma.</p> <p>Methods</p> <p>Reg IV mRNA and protein expression in human gliomas and non-neoplastic brain tissues were respectively detected by real-time quantitative RT-PCR assay, Western blot, and immunohistochemistry. The association of Reg IV immunostaining with clinicopathological factors and prognosis of glioma patients was also statistically analyzed.</p> <p>Results</p> <p>Reg IV mRNA and protein expression levels in glioma tissues were both significantly higher than those in the corresponding non-neoplastic brain tissues (both P < 0.001). Additionally, the increased Reg IV immunostaining in glioma tissues was significantly associated with advanced pathological grade (P = 0.008). Reg IV protein up-regulation was also significantly correlated with low Karnofsky performance score (KPS) (P = 0.02). Moreover, the overall survival of patients with high Reg IV protein expression was dramatically shorter than those with low Reg IV protein expression (P < 0.001). Multivariate Cox regression analysis further confirmed that Reg IV expression was an independent prognostic factor for patients with gliomas (P = 0.008).</p> <p>Conclusions</p> <p>These convinced evidences suggest for the first time that Reg IV might accelerate disease progression and act as a candidate prognostic marker for gliomas.</p> <p>Virtual slides</p> <p>The virtual slide(s) for this article can be found here:</p> <p><url>http://www.diagnosticpathology.diagnomx.eu/vs/2145344361720706</url></p> 
546 |a EN 
690 |a Regenerating islet-derived family member 4 
690 |a glioma 
690 |a RT-PCR 
690 |a Western blot 
690 |a Immunohistochemistry 
690 |a Prognosis 
690 |a Pathology 
690 |a RB1-214 
655 7 |a article  |2 local 
786 0 |n Diagnostic Pathology, Vol 7, Iss 1, p 69 (2012) 
787 0 |n http://www.diagnosticpathology.org/content/7/1/69 
787 0 |n https://doaj.org/toc/1746-1596 
856 4 1 |u https://doaj.org/article/adbb04d8b2b0402a9245f1b84c7890c4  |z Connect to this object online.